Molecular signatures of progression and chemoresistance in epithelial ovarian carcinoma
Author: Björklund, My
Date: 2014-11-28
Location: Lecture hall Medicin, A6:04, Karolinska University Hospital, Solna
Time: 09.30
Department: Inst för onkologi-patologi / Dept of Oncology-Pathology
View/ Open:
Thesis (10.12Mb)
Abstract
Epithelial ovarian carcinoma (EOC) is a heterogeneous disease generally classified into five
histopathological subtypes; low- and high-grade serous, endometrioid, clear cell and
mucinous carcinomas. Although each subtype has distinct clinical and molecular
characteristics, they are all treated with surgery and platinum/ taxane chemotherapy. Despite
initial responsiveness a majority of patients relapse into platinum-resistant and disseminated
disease. This, together with often late diagnosis, makes EOC the most lethal gynecological
cancer. Dissemination is mainly abdominal, via exfoliated tumor cells in peritoneal ascitic
fluid. The origin and phenotype of cells in malignant ascites is poorly understood. Tumor
progression of carcinomas towards metastasis includes epithelial-to-mesenchymal-transition
(EMT), where epithelial cells gain a mesenchymal morphology to facilitate invasion.
Progression and chemoresistance have also been attributed to a small population of highly
tumorigenic and chemoresistant cancer stem cells, or tumor-initiating cells (TICs). In
addition, altered cellular energetics is a hallmark of cancer wherefore tumor-specific
metabolic features are potential targets for overcoming chemoresistance.
In Paper I cell populations in malignant ascites were found to differ significantly with respect to protein expression levels of EMT and TIC markers. We identified two potential TIC profiles, highlighting a biological heterogeneity in ascitic tumor cell populations. The indicated presence of cancer-associated fibroblasts (CAFs) may further contribute to malignant properties. We found that CAF marker α-SMA expression was increased in clinical stage IV, compared to stage IIIC.
Paper II reveals that long-term repeated cisplatin treatment can select for and/or induce a multiresistant cell population with EMT and TIC features. Resistance could be linked to upregulation of VDAC and HK-II, which form an anti-apoptotic complex on mitochondria. Multiresistant cells were sensitive to the lactate/ pyruvate analogue 3-BP that dissociates this complex, and particularly sensitive to 3-BP when combined with cisplatin in low doses.
In Paper III expression of mitochondrial regulators PGC1α and TFAM was found to vary between EOC subtypes. For clear cell carcinomas (CCC) a profile consisting of low or undetectable levels of PGC1α, TFAM, ERα and low Ki-67 index was identified. This CCC profile, and also glycogen accumulation, was further linked to chemoresistance development in vitro.
In Paper IV we used 1H NMR-based metabolomics to identify significant differences in the intracellular polar metabolome of parental and multiresistant EOC cell lines. Furthermore, we developed a tailored and reliable protocol for metabolic profiling of adherent cells, suitable for further characterization of metabolic alterations in EOC and other pathological conditions.
Taken together, this thesis identifies signatures of progression and chemoresistance in EOC and highlights the need for subtype-specific treatment.
In Paper I cell populations in malignant ascites were found to differ significantly with respect to protein expression levels of EMT and TIC markers. We identified two potential TIC profiles, highlighting a biological heterogeneity in ascitic tumor cell populations. The indicated presence of cancer-associated fibroblasts (CAFs) may further contribute to malignant properties. We found that CAF marker α-SMA expression was increased in clinical stage IV, compared to stage IIIC.
Paper II reveals that long-term repeated cisplatin treatment can select for and/or induce a multiresistant cell population with EMT and TIC features. Resistance could be linked to upregulation of VDAC and HK-II, which form an anti-apoptotic complex on mitochondria. Multiresistant cells were sensitive to the lactate/ pyruvate analogue 3-BP that dissociates this complex, and particularly sensitive to 3-BP when combined with cisplatin in low doses.
In Paper III expression of mitochondrial regulators PGC1α and TFAM was found to vary between EOC subtypes. For clear cell carcinomas (CCC) a profile consisting of low or undetectable levels of PGC1α, TFAM, ERα and low Ki-67 index was identified. This CCC profile, and also glycogen accumulation, was further linked to chemoresistance development in vitro.
In Paper IV we used 1H NMR-based metabolomics to identify significant differences in the intracellular polar metabolome of parental and multiresistant EOC cell lines. Furthermore, we developed a tailored and reliable protocol for metabolic profiling of adherent cells, suitable for further characterization of metabolic alterations in EOC and other pathological conditions.
Taken together, this thesis identifies signatures of progression and chemoresistance in EOC and highlights the need for subtype-specific treatment.
List of papers:
I. Wintzell M, Hjerpe E, Åvall-Lundqvist E and Shoshan M. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites BMC Cancer 2012;12:359.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Wintzell M, Löfstedt L, Johansson J, Pedersen AB, Fuxe J and Shoshan M. Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate Cancer Biol Ther 2012;13:14,1454-1462.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Gabrielson M, Björklund M, Carlson J and Shoshan M. Expression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinoma PloS One 2014; 9: e107109
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Engskog M, Björklund M, Haglöf J, Arvidsson T, Shoshan M and Pettersson C. Metabolic profiling of epithelial ovarian cancer cell lines: evaluation of harvesting protocols for profiling using NMR spectroscopy. [Accepted]
Pubmed
View record in Web of Science®
I. Wintzell M, Hjerpe E, Åvall-Lundqvist E and Shoshan M. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites BMC Cancer 2012;12:359.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Wintzell M, Löfstedt L, Johansson J, Pedersen AB, Fuxe J and Shoshan M. Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate Cancer Biol Ther 2012;13:14,1454-1462.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Gabrielson M, Björklund M, Carlson J and Shoshan M. Expression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinoma PloS One 2014; 9: e107109
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Engskog M, Björklund M, Haglöf J, Arvidsson T, Shoshan M and Pettersson C. Metabolic profiling of epithelial ovarian cancer cell lines: evaluation of harvesting protocols for profiling using NMR spectroscopy. [Accepted]
Pubmed
View record in Web of Science®
Institution: Karolinska Institutet
Supervisor: Shoshan, Maria
Issue date: 2014-11-07
Rights:
Publication year: 2014
ISBN: 978-91-7549-670-2
Statistics
Total Visits
Views | |
---|---|
Molecular ...(legacy) | 961 |
Molecular ... | 222 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Molecular ... | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
File Visits
Views | |
---|---|
Thesis_My_Björklund.pdf | 836 |
Thesis_My_Björklund.pdf(legacy) | 717 |
Thesis_mybjo.pdf(legacy) | 1 |
Top country views
Views | |
---|---|
United States | 340 |
Sweden | 197 |
China | 91 |
Germany | 91 |
South Korea | 41 |
India | 26 |
Poland | 18 |
United Kingdom | 17 |
Austria | 16 |
Australia | 15 |
Top cities views
Views | |
---|---|
Ashburn | 52 |
Sunnyvale | 48 |
Stockholm | 46 |
Seoul | 36 |
Herndon | 30 |
Wilmington | 28 |
Kiez | 23 |
Kraków | 17 |
Shenzhen | 16 |
Vienna | 14 |